Special Achievements
Activities
 
 
Health Check - Up
 
 
 

 
 
 
 ABOUT THE DEPARTMENT
     
 

The Department of Assisted Reproduction and Genetics, Jaslok Hospital and Research Centre, Mumbai, India, has been functional since October 1990. During this period we have had the privilege to treat more than 6000 couples from every state of India and from 35 different countries resulting in the birth of over 1600 babies.

We have state-of-the art facilities for In Vitro Fertilization (IVF), Micromanipulation (ICSI), Laser Assisted Hatching (LAH), Semen and Embryo Cryopreservation and a fully functional Andrology Laboratory for diagnostic and therapeutic tests. Facilities for Genetic tests utilize an automated Karyotyping Workstation for chromosome analysis and Fluoresecnce in situ hybridization (FISH) and advanced equipment for molecular genetic tests like the Polymerase Chain Reaction (PCR). Prenatal, Postnatal and Preimplantation Genetic Diagnostic tests (PGD) are carried out in our laboratory.

Couples with female or male infertility are counseled for both medical and surgical causes of infertility. We offer treatment for ovulatory disorders and other endocrine problems which cause infertility. Endoscopy & surgical management of infertility is also carried out. We have a large series of more than 2000 cases of endoscopy including operative laparoscopy and hysteroscopy.

The science of Assisted Reproduction has moved forward by leaps and bounds. Since its inception in 1990 the Department of Assisted Reproduction & Genetics has endeavored to help infertile couples, to have normal babies. We pledge to continue our research to enhance medical technology in order to help couples realize their dream of having a healthy child.

 
     
  Click here to read more about the Department  
     
   
   
     
 FACILITIES & SERVICES
     
 
  • In-vitro fertilization (IVF), Intracytoplasmic sperm injection (ICSI)
  • Laser Assisted Hatching
  • Blastocyst transfer
  • Cryopreversation of sperm
  • Cryopreversation of embryos
  • Donor oocyte/donor embryo program
  • Isolation of sperm from testicular biopsy (TESA)
  • Percutaneous epididymal sperm aspiration (PESA)
  • Detailed Semen analysis
  • Sperm preparation for intra-uterine insemination
  • Intra-uterine insemination (IUI)
  • Treatment of ovulation disorders, hirsuitism, premature menopause
  • Endoscopic and surgical management of infertility
  • Preimplantation Genetic Diagnosis from clevage-stage embryos by fluorescence in-situ hybridization (FISH)
  • Psychiatric Counseling
 
     
  Genetics  
     
 

Karyotyping

  • Karyotyping from Blood (routine)
  • Karyotyping for Prenatal diagnosis
  • Karyotyping from Products of Conception
  • Karyotyping and Fragile X detection
  • Karyotyping and chromosome breakage study for Fanconi Anemia
  • Karyotyping in Cancer (Leukemias) from bone-marrow
 
     
  Fluorescence in situ hybridization (FISH)  
     
 
  • FISH for Aneuploidy Detection (chromosomes 13, 18, 21, X and Y)
  • FISH on sperm
  • FISH for preimplantation genetic diagnosis (PGD)
  • FISH on Buccal Smears
  • FISH for microdeletion of SNRPN in Prader-Willi/Angelman Syndrome
  • FISH for Duplication of D15S11 in autism.
  • FISH for BCR/ABL gene fusion - semiquantitative analysis.
    (translocation 9/22 in chronic myeloid leukemia)
  • FISH for PML/RARA gene fusion - semiquantitative analysis
    (translocation 15/17 in AML-M3)
 
     
  Polymerase Chain Reaction (PCR)  
     
 
  • Y chromosome microdeletion detection in cases of male infertility
    (20 microdeletions by multiplex PCR)

Cystic Fibrosis mutation detection in cases of congenital absence of vas deferens

 
     
   
   
  RESEARCH PROJECTS
     
 

  1. Characterization of chromosome anomalies, Y microdeletions and Cystic Fibrosis mutations in male infertility.
    A significant proportion (60%) of male infertility is due to an underlying genetic cause. The use of intracytoplasmic sperm injection (ICSI) raises a possibility of transgenerational transmission of genetic defects to the offspring where the father has a genetic abnormality such as Y chromosome microdeletions. For proper management of these couples, counseling after clinical investigation, semen analysis, a karyotype and a DNA analysis to rule out Y chromosome microdeletions were carried out.

    At least three distinct non-overlapping regions on the Y chromosome, named as AZFa, AZFb and AZFc for azoospermia factors a, b and c are critical for germ-cell differentiation. A fourth locus AZFd has been suggested afterwards which lies between loci AZFb and AZFc. Y chromosome microdeletion detection was carried out on 100 males with a history of either azoospermia, severe oligozoospermia, oligozoospermia or oligoasthenoteratozoospermia (OAT). Multiplex PCR was set up using the Promega kit Version 1.1 for 18 mutations in the AZF (azoospermia factor) a, b, c & d regions. The PCR products were analyzed on 2.5% agarose gel by electrophoresis. Y chromosome microdeletions were observed in 12 out of 100 patients (12%).

    We are now using the modified version of Y chromosome microdeletion detection kit as Version 2.0 from Promega which includes 20 mutations.



  2. Cytogenetic and Molecular Analysis of the Fragile X Syndrome.
    Fragile-X syndrome is a genetic condition mainly leading to mental retardation in males. It is caused by a fragile site at the tip of the long arm of the X chromosome, which is demonstrable on karyotyping using special tissue culture media. However, cytogenetic methods are not very reliable for Fragile X detection, compared to molecular techniques. Molecular studies have shown the presence of an increasing number of CGG trinucleotide repeats in every generation. A carrier mother may have 60-200 repeats and an affected son will have >200 repeats in the FMR-1 gene. Southern blotting with radioactive detection and PCR are used for molecular diagnosis. There is hardly any data on Fragile X patients from western India. The aim of this study is to try and develop a non-radioactive molecular method for detection of Fragile X, using Silver staining detection for PCR analysis and chemiluminescence detection for Southern hybridization. Children from special schools will be studied to identify families at risk of transmitting this condition and offer prenatal diagnosis to prevent the birth of other affected children.


  3. FISH on Follicular Fluid to detect Gonadal Sex Chromosome Mosaicism in women undergoing infertility treatment
    Gonadal chromosome mosaicism is difficult to diagnose as a gonadal biopsy is required. This cannot be used as a routine procedure. In infertile females undergoing in vitro fertilization (IVF) follicular fluid is obtained during oocyte pick-up. After collecting the oocytes for IVF, the surrounding follicular fluid is generally discarded. We studied the cumulus cells present in follicular fluid by the fluorescence in situ hybridization (FISH) technique and found that this was a novel way of detecting aneuploidy in the ovarian tissue. We could detect Turner syndrome mosaicism in this tissue in a cytogenetically proven case of Turner syndrome mosaicism undergoing IVF. The percentage of chromosomal mosaicism is known to vary in different tissues. We could demonstrate that follicular fluid cells are an easily available alternate source of cells to detect chromosome mosaicism by FISH, in patients undergoing IVF. The study is ongoing to collect more data on follicular fluid cells and compare it with karyotyping from blood and FISH on buccal smears.


  4. In Vitro Maturation of Germinal Vesicle Oocytes
    In an IVF cycle, about 8.5% of retrieved oocytes are immature, at the germinal vesicle stage. Complete maturation of oocytes is essential for the developmental competence of embryos. Human oocyte maturation is considered as the re-initiation and completion of the first meiotic division from the germinal vesicle stage (prophase I) to metaphase II and the accompanying cytoplasmic maturation, for fertilization and early embryonic development. Immature human oocytes obtained from patients undergoing oocyte retrieval can be matured and fertilized in vitro. In vitro maturation is slowly becoming established as an alternative treatment option to stimulated IVF for women requiring assisted conception. Germinal vesicle stage cumulus-oocyte complexes collected from patients undergoing oocyte retrieval are being cultured in maturation medium with supplements and those that reach the M2 stage undergo intra-cytoplasmic sperm injection (ICSI). Clevage-stage embryos are obtained. The overall maturation, fertilization and cleavage rates after ICSI of 150 germinal vesicle stage cumulus-oocyte complexes will be determined.


  5. Fluorescent in situ hybridization (FISH) in slowly cleaving and arrested embryos.
    Reproductive wastage is a natural phenomenon to eliminate defective embryos. This has been confirmed by cytogenetic studies on spontaneous abortions and recently, on arrested embryos. The Fluorescence in situ Hybridization (FISH) technique enables rapid detection of common aneuploidies. A contributory cause of IVF failure is a high number of zygotes with missing or extra chromosomes. Individual blastomeres from slowly cleaving and arrested embryos which are of no use in IVF are biopsied using a non-contact diode laser beam, treated with hypotonic solution and fixed on slides with an effort to remove the cytoplasm and expose the intact nucleus. The nucleii are located under phase contrast and photographed. FISH for common aneuploidies is performed on these single cells. The signals are analysed to detect aneuploid, mosaic and chaotic embryo
 
 
 
   
  DOCTORS IN ATTENDANCE
     
 
  Co-Ordinator    
  Dr. Parikh Firuza R    
       
  Hon.Consultant Ivf    
  Dr. Parikh Firuza R    
  Dr. Tripti Mehta     
       
  Hon. Consultant Geneticist    
  Dr. Prochi F Madon    
       
  Sr.Research Officer    
  Dr. Nadkarni Suparna    
 
 
     
   


 
 
Contact Details l Sitemap
Site Designed & Developed by E Vision Technologies